Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct 17;2(4):755-71.
doi: 10.3390/vaccines2040755.

Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications

Affiliations
Review

Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications

Minoru Kidokoro et al. Vaccines (Basel). .

Abstract

The LC16m8 strain of vaccinia virus, the active ingredient in the Japanese smallpox vaccine, was derived from the Lister/Elstree strain. LC16m8 is replication-competent and has been administered to over 100,000 infants and 3,000 adults with no serious adverse reactions. Despite this outstanding safety profile, the occurrence of spontaneously-generated large plaque-forming virulent LC16m8 revertants following passage in cell culture is a major drawback. We identified the gene responsible for the reversion and deleted the gene (B5R) from LC16m8 to derive LC16m8Δ. LC16m8∆ is non-pathogenic in immunodeficient severe combined immunodeficiency (SCID) mice, genetically-stable and does not reverse to a large-plaque phenotype upon passage in cell culture, even under conditions in which most LC16m8 populations are replaced by revertants. Moreover, LC16m8∆ is >500-fold more effective than the non-replicating vaccinia virus (VV), Modified Vaccinia Ankara (MVA), at inducing murine immune responses against pathogenic VV. LC16m8∆, which expresses the SIV gag gene, also induced anti-Gag CD8⁺ T-cells more efficiently than MVA and another non-replicating VV, Dairen I minute-pock variants (DIs). Moreover, LC16m8∆ expressing HIV-1 Env in combination with a Sendai virus vector induced the production of anti-Env antibodies and CD8⁺ T-cells. Thus, the safety and efficacy of LC16m8∆ mean that it represents an outstanding platform for the development of human vaccine vectors.

Keywords: B5R; DIs; HIV; LC16m8; LC16m8∆; MVA; SIV; reversion; vaccinia virus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathogenicity of B5R-defective viruses in severe combined immunodeficiency (SCID) mice. Figure modified from Kidokoro et al. [34].
Figure 2
Figure 2
Genetic stability of LC16m8∆ and LC16m8 upon serial passage in primary rabbit kidney cells at different temperatures (30 °C or 34 °C). Figure modified from Kidokoro et al. [34]. LPC, large-plaque-forming clone.
Figure 3
Figure 3
(A) Protective immune responses induced by m8∆ and derivative viruses in mice. (AF) Average body weight of mice immunized (intramuscularly) with (104–106 PFU) vaccinia viruses (VVs) and then challenged intranasally with the Western Reserve (WR) strain. Crosses denote mice that either died or were sacrificed because they lost >30% of their body weight. Figure modified from Kidokoro et al. [34].

Similar articles

Cited by

References

    1. Fenner F., Henderson D.A., Arita I., Jezek Z., Ladnyi I.D., Organization W.H. Smallpox and Its Eradication. World Health Organization; Geneva, Switzerland: 1988.
    1. Wehrle P.F. A reality in our time—Certification of the global eradication of smallpox. J. Infect. Dis. 1980;142:636–638. doi: 10.1093/infdis/142.4.636. - DOI - PubMed
    1. Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., Hauer J., Layton M., McDade J., Osterholm M.T., et al. Smallpox as a biological weapon: Medical and public health management. Working group on civilian biodefense. JAMA. 1999;281:2127–2137. doi: 10.1001/jama.281.22.2127. - DOI - PubMed
    1. Reed K.D., Melski J.W., Graham M.B., Regnery R.L., Sotir M.J., Wegner M.V., Kazmierczak J.J., Stratman E.J., Li Y., Fairley J.A., et al. The detection of monkeypox in humans in the western hemisphere. N. Engl. J. Med. 2004;350:342–350. doi: 10.1056/NEJMoa032299. - DOI - PubMed
    1. The Centers for Disease Control and Prevention Multistate outbreak of monkeypox—Illinois, indiana, and wisconsin, 2003. JAMA. 2003;290:30–31. - PubMed

LinkOut - more resources